News from the department of Dermatology
Latest entry in the department of Dermatology:
Lanadelumab
Lanadelumab Definition Lanadelumab is a fully human monoclonal antibody (IgG1/κ light chain). Lanadelumab inhibits the proteolytic activity of active plasma kallikrein. Increased plasma kallikrein activity leads to angioedema attacks in patients with HAE through proteolysis of high molecular weig...
Go to articleRecent search terms:
70,266
Articles
181,008
Sections
17,174
Images
Prof. Dr. med. Peter Altmeyer
Editor-in-Chief
One of Germany's most accomplished dermatologists with decades of expertise in clinical dermatology. Emeritus professor at the Ruhr-Universität Bochum, author of more than 30 textbooks and over 700 scientific publications.